The top global medtech industry dynamics identified by the G-MedTech Research team over the past week.

GE HealthCare acquires MIM Software, a Cleveland-based provider of medical imaging analysis and AI solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology, to strengthen its practice of precision medicine across multiple disease states and imaging modalities.

Boston Scientific acquires Axonics, a public company focused on the development and commercialization of differentiated devices for the treatment of urinary and bowel dysfunction.

KARL STORZ acquires Innersight Labs, a London-based software innovator that will advance AI in laparoscopic and robotic imaging solutions.

Veracyte acquires C2i Genomics, a minimal residual disease detection company, for up to $95 million.

Integer acquires Pulse Technologies, a Pennsylvania-based company focused on implantable medical components and assemblies for high-growth market segments,y, for approximately $140 million.

CardioFocus acquires the electrophysiology technology division of Galvanize Therapeutics, including the CENTAURI System pulsed electric field generator and the QuickShot™ catheter ablation system.

ab medica, the leading Italian distributor of breakthrough robotic technologies, will expand the global commercialization of Medical Microinstruments’ Symani Surgical System.

ZOLL receives FDA clearance and CE mark for a significant upgrade to the versatility of the Thermogard™ Temperature Management System, which is now the first and only system to offer the versatility of both core and surface-based temperature management treatment options.

Butterfly Network receives FDA clearance of its next-generation Butterfly iQ3 point-of-care ultrasound system, the third iteration of the world’s first semiconductor-based, single-probe, whole-body ultrasound system.

Occlutech® receives FDA clearance for the Occlutech® ASD Occluder and Occlutech® Pistol Pusher for the treatment of atrial septal defects (ASD).

Cleerly launches the recently FDA approved Cleerly ISCHEMIA analysis software, an automated machine learning-based decision support tool intended as a diagnostic aid for patients undergoing coronary computed tomography angiography (CCTA) analysis using Cleerly Labs software.

Hyperfine launches the eighth generation of its AI-powered Swoop® system software, which enhances the image quality of the Swoop® system and introduces valuable ease-of-use features, including real-time assistance for more accurate patient loading and positioning, and a streamlined image upload process.

Oxford, UK-based Ultromics collaborates with Pfizer to support the development of its AI-based technology for the detection of cardiac amyloidosis.

Medtronic announces CE Mark approval for the MiniMed™ 780G System with Simplera Sync™, an all-in-one disposable continuous glucose monitor that requires no fingertips.

Medtronic receives FDA approval for Percept™ RC Deep Brain Stimulation system, a rechargeable neurostimulator that is the latest innovation in the Medtronic Percept™ family, which includes the Percept™ PC neurostimulator, BrainSense™ technology, and SenSight™ directional leads.

AIRS Medical receives EU Medical Device Regulation (MDR) CE marking for its SwiftMR™ AI-based MRI enhancement solution, which will be sold in 27 EU countries, Turkey, EEA (Liechtenstein, Iceland, Norway), the UK and Switzerland.

Zeta Surgical receives FDA special 510(k) clearance of its Zeta Cranial Navigation System for expanded functionality through enhanced software features and compatibility with additional accessories.

Darmiyan receives FDA clearance for BrainSee software designed to help physicians determine the prognosis of patients with amnestic mild cognitive impairment (aMCI), marking a significant advancement in brain health and opening the door to untapped market potential in the diagnosis and management of brain disorders.

3M Health Care’s Medical Solutions Division is awarded $34.2 million by the U.S. Army Medical Research Acquisition Activity to develop a range of new solutions for infection prevention, wound management and wound healing.

Shanghai, China-based Bebig Medical closes over RMB 100 million ($14 million) Series B financing from Cathay Capital to support the global commercialization of its linear accelerator and intraoperative radiotherapy technologies.

Shenzhen, China-based Keylights Technology closes nearly RMB 100 million ($14 million) Series B financing led by Lucino Venture Capital to accelerate the commercialization of its full range of in vitro diagnostic instruments for chemiluminescence, immunofluorescence, flow fluorescence, and mass spectrometry pre-processing.

Linstant Polymer Materials, a Ningbo, China-based medical device accessory manufacturer that provides “one-to-one” customized solutions for minimally invasive medical device companies, closes over RMB 100 million ($14 million) Series B financing to expand production, attract talent and develop new overseas markets.

This article is available in multi languages.

en_GBEnglish (UK)